Literature DB >> 11080707

Validation of a pediatric asthma caregiver diary.

N C Santanello1, C Demuro-Mercon, G Davies, N Ostrom, M Noonan, A Rooklin, B Knorr.   

Abstract

BACKGROUND: Young children are generally not able to consistently and reliably perform tests of airway function, and normative values are not available. Reliable and valid measures of parental reporting of asthma symptoms and functioning are needed to determine the efficacy of asthma interventions.
OBJECTIVE: A pediatric asthma caregiver diary was developed and validated for use in interventional asthma studies.
METHODS: A 3-week prospective study of 125 caregiver parents and their children, aged 2 to 5 years, with persistent asthma was conducted. At baseline, children were classified as either stable (no change to anti-inflammatory therapy) or unstable (anti-inflammatory therapy added or increased).
RESULTS: A symptom scale and day without asthma symptoms (DWAS) were defined from pediatric asthma caregiver diary questions. The scale and DWAS statistically differentiated between the stable and unstable groups at week 1 and detected change between the 2 groups (P <.01). On average, caregivers reported low symptom scores. However, the frequency of DWAS was only 43% of days in the stable group and 22% in the unstable group.
CONCLUSION: The pediatric asthma caregiver diary scale and DWAS have acceptable measurement characteristics for use in clinical trials of children with asthma symptoms. The DWAS indicates an opportunity for improvement in asthma control in this population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080707     DOI: 10.1067/mai.2000.110478

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

Review 1.  Asthma outcomes: symptoms.

Authors:  Jerry A Krishnan; Robert F Lemanske; Glorisa J Canino; Kurtis S Elward; Meyer Kattan; Elizabeth C Matsui; Herman Mitchell; E Rand Sutherland; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Daily or intermittent budesonide in preschool children with recurrent wheezing.

Authors:  Robert S Zeiger; David Mauger; Leonard B Bacharier; Theresa W Guilbert; Fernando D Martinez; Robert F Lemanske; Robert C Strunk; Ronina Covar; Stanley J Szefler; Susan Boehmer; Daniel J Jackson; Christine A Sorkness; James E Gern; H William Kelly; Noah J Friedman; Michael H Mellon; Michael Schatz; Wayne J Morgan; Vernon M Chinchilli; Hengameh H Raissy; Elizabeth Bade; Jonathan Malka-Rais; Avraham Beigelman; Lynn M Taussig
Journal:  N Engl J Med       Date:  2011-11-24       Impact factor: 91.245

3.  Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Karin B Yeatts; Brian Stucky; David Thissen; Deb Irwin; James W Varni; Esi Morgan DeWitt; Jin-Shei Lai; Darren A DeWalt
Journal:  J Asthma       Date:  2010-04       Impact factor: 2.515

Review 4.  Measures of asthma control.

Authors:  Christian Bime; Jessica Nguyen; Robert A Wise
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

5.  Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?

Authors:  Avraham Beigelman; Tonya S King; David Mauger; Robert S Zeiger; Robert C Strunk; H William Kelly; Fernando D Martinez; Robert F Lemanske; Katherine Rivera-Spoljaric; Daniel J Jackson; Theresa Guilbert; Ronina Covar; Leonard B Bacharier
Journal:  J Allergy Clin Immunol       Date:  2013-03-14       Impact factor: 10.793

6.  Daily diaries vs retrospective questionnaires to assess asthma control and therapeutic responses in asthma clinical trials: is participant burden worth the effort?

Authors:  Adesua Y Okupa; Christine A Sorkness; David T Mauger; Daniel J Jackson; Robert F Lemanske
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

7.  Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.

Authors:  Leonard B Bacharier; Brenda R Phillips; Robert S Zeiger; Stanley J Szefler; Fernando D Martinez; Robert F Lemanske; Christine A Sorkness; Gordon R Bloomberg; Wayne J Morgan; Ian M Paul; Theresa Guilbert; Marzena Krawiec; Ronina Covar; Gary Larsen; Michael Mellon; Mark H Moss; Vernon M Chinchilli; Lynn M Taussig; Robert C Strunk
Journal:  J Allergy Clin Immunol       Date:  2008-10-30       Impact factor: 10.793

Review 8.  Exhaled nitric oxide in the clinical management of asthma.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

9.  Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations.

Authors:  F M Ducharme; R Zemek; J Gravel; D Chalut; N Poonai; S Laberge; C Quach; M Krajinovic; C Guimont; C Lemière; M C Guertin
Journal:  BMJ Open       Date:  2014-04-07       Impact factor: 2.692

Review 10.  Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.

Authors:  Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia
Journal:  Front Pediatr       Date:  2018-06-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.